Terho Heikkinen
Professor of Paediatrics, MD, PhD
teheikki@utu.fi |
Paediatric infectious diseases; respiratory infections; respiratory viruses; vaccinations; influenza; respiratory syncytial virus; otitis media
Respiratory infections in children; RESCEU (EU/IMI-funded project 2017-2021); INFORM study
Professor Terho Heikkinen graduated from the Medical School at the
University of Turku in 1984, where he also specialized in Paediatrics and Paediatric
Infectious Diseases. He defended his thesis on Development and prevention of acute
otitis media in children in 1994. Having received the European Society for
Paediatric Infectious Diseases Fellowship Award, he worked in 1996-1998 as
a post-doc Research Fellow at the University of Texas Medical Branch at
Galveston, USA. Subsequently, he worked as a Senior Clinical Researcher and
Clinical Lecturer at the Department of Paediatrics, University of Turku. Since
2016, he has been Professor of Paediatrics at
the Faculty of Medicine, University of Turku.
During the years, Terho Heikkinen has served as the chairman or a board member
of several international and domestic societies in the field of paediatric
infectious diseases, including the President of the World Society for
Pediatric Infectious Diseases. He is currently a board member of the European Scientific
Working Group on Influenza (ESWI), a scientific advisory board and executive committee member of the global Respiratory Syncytial Virus Network (ReSViNET), and the chairman of the Nordic Research Network for Paediatric Infectious Diseases (NORDPID).
Terho Heikkinen´s major research interest lies in respiratory infections,
especially those caused by influenza or respiratory syncytial viruses. In year 2000, he founded his own research group and initiated a long-term research project on respiratory virus infections in children,
including the etiology, epidemiology, diagnosis, treatment, prevention, and
overall societal impact of these infections and their complications.
Terho Heikkinen has been
actively involved in international research collaboration. In 2014, he was a founding member of ReSViNET, a global respiratory syncytial virus research network.
He is also a principal investigator in RESCEU (Respiratory syncytial virus
consortium in Europe) that in 2017 received 5-year EU/IMI funding for research
on the burden of respiratory syncytial virus infections in Europe. He was also a founding member of the Nordic Research Network for Paediatric Infectious Diseases (NORDPID) that was established in 2018.
Since 1999, Terho Heikkinen has worked as a full-time
teacher of paediatrics at the Department of Paediatrics, University of Turku. He
is also responsible for the organization of the biannual International Course
of Paediatrics & Adolescent Medicine for international Erasmus students. He
has given 188 invited lectures at various international and domestic academic
meetings.
- Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe (2023)
- Vaccine
- Hengitystieinfektiot: influenssa (2023) Lastentaudit Peltola Ville, Heikkinen Terho
- Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data (2023)
- Lancet Infectious Diseases
- Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape (2023)
- Lancet Infectious Diseases
- The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study (2023)
- The Lancet Respiratory Medicine
- Trends and Changes in Influenza-associated Hospitalizations in Children During 25 Years in Finland, 1993–2018 (2023)
- Pediatric Infectious Disease Journal
- Age-Specific Estimates of Respiratory Syncytial Virus-Associated Hospitalizations in 6 European Countries: A Time Series Analysis (2022)
- Journal of Infectious Diseases
- A Systematic Review of European Clinical Practice Guidelines for Respiratory Syncytial Virus Prophylaxis (2022)
- Journal of Infectious Diseases
- Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis (2022)
- Lancet
- Lasten influenssainfektioita ei pidä unohtaa: lasten influenssasta aiheutuvan tautitaakan keventäminen on tärkeää koko yhteiskunnalle (2022)
- Duodecim
- Respiratory Syncytial Virus-Associated Hospital Admissions and Bed Days in Children <5 Years of Age in 7 European Countries (2022)
- Journal of Infectious Diseases
- Burden of influenza during the first year of life (2021)
- Influenza and Other Respiratory Viruses
- Burden of Respiratory Syncytial Virus Infection During the First Year of Life (2021)
- Journal of Infectious Diseases
- Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus (2021)
- Nature Communications
- Global Molecular Epidemiology of Respiratory Syncytial Virus from the 2017-2018 INFORM-RSV Study (2021)
- Journal of Clinical Microbiology
- Oseltamivir treatment of influenza A and B infections in infants (2021)
- Influenza and Other Respiratory Viruses
- Acute Lower Respiratory Infections Associated With Respiratory Syncytial Virus in Children With Underlying Congenital Heart Disease: Systematic Review and Meta-analysis (2020)
- Journal of Infectious Diseases
- Association Between Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection in Early Life and Recurrent Wheeze and Asthma in Later Childhood (2020)
- Journal of Infectious Diseases
- Association of Viral Load With Disease Severity in Outpatient Children With Respiratory Syncytial Virus Infection (2020)
- Journal of Infectious Diseases
- A Systematic Review of Clinical Practice Guidelines for the Diagnosis and Management of Bronchiolitis (2020)
- Journal of Infectious Diseases